ProCE Banner Events

Share

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

Gain expert insight on current best practices and emerging strategies for using BCMA-targeted therapies in relapsed/refractory multiple myeloma in these interactive, expert led 1-hour CME/CNE/CPE-certified workshops

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

This event has expired. No longer available for credits.

Credits Available

1.0

Who Should Attend

This program is intended for hematologists, oncologists, nurses, pharmacists, and other HCPs on the multidisciplinary team caring for patients with multiple myeloma.

Time and location

Tuesday, July 11, 2023

6:00 PM - 7:00 PM Central Time (CT)

Virtual

CCO Simulcast | Host Group TX
San Antonio, Texas

Agenda

  • BCMA-Targeted Therapy in Multiple Myeloma: Advantages and Disadvantages
  • Understanding the Different Classes of BCMA-Targeted Therapies
  • Strategies to Mitigate BCMA Exhaustion and New Frontiers

Location

Venue Name

CCO Simulcast | Host Group TX

Address

CCO Simulcast | Host Group TX
San Antonio, Texas

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ knowledge of, competence in, and performance in applying practice-changing clinical data and expert recommendations to integrate the use of BCMA-targeted agents for their patients with multiple myeloma.

Target Audience
This program is intended for hematologists, oncologists, nurses, pharmacists, and other HCPs on the multidisciplinary team caring for patients with multiple myeloma.

Learning Objectives:

  • Describe to patients the advantages and disadvantages for the 3 mechanisms of action for targeting BCMA
  • Identify patients with multiple myeloma who are likely to benefit from treatment with currently available BCMA-targeted therapy
  • Plan therapeutic strategies using BCMA-targeted therapies for patients with multiple myeloma, considering available efficacy, safety, and tolerability data along with guideline and expert recommendations
  • Identify mechanisms of resistance that can affect sequential use of BCMA-targeting agents
  • Monitor and mitigate potential adverse events from anti-BCMA therapy in patients with multiple myeloma, including but not limited to ocular toxicity, cytokine-release syndrome, and neurotoxicity

Accreditation

Joint Accreditation Statement

A picture containing shapeDescription automatically generated

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity will be 1.0 contact hour.

Continuing Pharmacy Education

A picture containing text, window, clipartDescription automatically generated

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-23-120-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from Bristol Myers Squibb and Regeneron Pharmaceuticals, Inc.

Contact Information

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.